Earnings call transcript: Kits Eyecare Q2 2025 reports revenue growth but EPS miss

Kits Eyecare Ltd reported its second-quarter 2025 earnings, revealing a record revenue of $49.6 million, which exceeded forecasts. However, the company posted an unexpected loss in earnings per share (EPS) of -0.02 USD, missing the predicted 0.0283 USD. Despite the revenue beat, the stock price fell by 2.01% to $16.59, reflecting investor concerns over the EPS miss. According to InvestingPro data, the company maintains strong financial health with an overall score of 3.05 (rated as GREAT), suggesting the recent price decline might present an opportunity for investors.

Key Takeaways

• Kits Eyecare reported a record revenue of $49.6 million, up 31% year-over-year.
• The company experienced an EPS loss of -0.02 USD, against a forecasted profit.
• Stock price decreased by 2.01% following the earnings release.
• Active customer base grew to 991,000, with repeat customers contributing over 60% of revenue.
• The company launched OpticianAI, enhancing its digital offerings.

Company Performance

Kits Eyecare continues to show strong performance in revenue growth, achieving a 31% increase compared to the previous year. This marks the eleventh consecutive quarter of positive adjusted EBITDA, highlighting the company’s consistent operational efficiency. The active customer base expanded by 13% year-over-year, indicating successful customer retention and acquisition strategies.

Financial Highlights

• Revenue: $49.6 million, up 31% year-over-year.
• Adjusted EBITDA: $2.6 million, representing 5.2% of revenue.
• Gross margin: Expanded by 3.5 basis points to 36.3%.
• Total active customers: 991,000, a 13% increase YoY.

Earnings vs. Forecast

Kits Eyecare’s actual EPS of -0.02 USD was significantly below the forecasted 0.0283 USD, resulting in a negative surprise of 170.67%. While the revenue exceeded expectations by 1.16%, the EPS miss is notable compared to previous quarters’ trends.

Market Reaction

Following the earnings announcement, Kits Eyecare’s stock fell by 2.01% to $16.59. This movement reflects investor disappointment with the EPS miss, despite the positive revenue growth. The stock is trading within its 52-week range, with a high of $17.71 and a low of $7.13.

Outlook & Guidance

For the third quarter, Kits Eyecare projects revenue between $52 million and $54 million, with an adjusted EBITDA margin of 5-7%. The company aims for a long-term gross margin target of 45% and an EBITDA margin of 15-20%, focusing on customer acquisition and lifetime value. InvestingPro analysis shows the company’s current gross margin at 34.81%, with analysts forecasting continued sales growth this year. The company’s PEG ratio of 0.25 suggests attractive valuation relative to its growth prospects.

Executive Commentary

CEO Roger Hardy emphasized the company’s commitment to building lifetime customer relationships, stating, "We’re in the business of building lifetime customer relationships." COO Joe Thompson highlighted the importance of technology in the company’s strategy, saying, "Our view is technologies like Optician AI will reach an intercept point where online becomes superior to in-store."

Risks and Challenges

• Ongoing EPS challenges could affect investor confidence.
• Increased marketing expenses, now at 15.2% of revenue, may impact profitability.
• Market competition in the digital eye care sector remains intense.
• Economic factors and consumer spending trends could influence future performance.
• Technological advancements require continuous investment and development.

Q&A

During the earnings call, analysts inquired about the "Own This Town" marketing strategy and the impact of the first-pair-free customer acquisition approach. Executives also discussed the potential of OpticianAI technology and its role in the future of online prescription and eyewear selection.

Full transcript - Kits Eyecare Ltd (KITS) Q2 2025:

Conference Operator: Good morning, and welcome to the KITS Eye Care Second Quarter twenty twenty five Financial Results Conference Call. This call is being recorded and available later today for replay. Your hosts today are Roger Hardy, Chief Executive Officer Joseph Thompson, Chief Operating Officer and Zei Chew, Chief Financial Officer. Before we begin, I’m required to provide the following statement respecting forward looking information, which is made on behalf of KITS and all of its representatives on this call. Certain statements made on this call will contain forward looking information.

These forward looking statements generally can be identified by the use of the words such as intend, believe, could, expect, estimate, forecast, may, would, and other words of similar meaning. This forward looking information is based on management’s opinions, estimates, and assumptions in light of their experience and perception of historical trends, current conditions, and expected future developments, as well as factors that they currently believe are appropriate and reasonable in the circumstances. Actual results could differ materially from a conclusion, forecast, expectation, belief or projection in the forward looking information, and certain material factors and assumptions were applied in drawing a conclusion or making a forecast or projection as reflected in the forward looking information. Management cautions investors not to rely on forward looking information. Additional information about the material factors that could cause actual results to differ materially from the conclusion, forecast or projection in the forward looking information and material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection as reflected in the forward looking information are contained in KIT’s filings with the Canadian provincial security regulators.

During today’s call, all figures are in Canadian dollars unless otherwise stated. And with that, I’d like to turn the call over to Mr. Roger Hardy. Please go ahead.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Good morning and thank you all for joining us today. We’re excited to share our Q2 twenty twenty five results, which reflect continued execution on our mission to make eye care easy. Kits delivered strong performance in the second quarter, underscoring the durability of our model and the distinctiveness of our strategy. We continue to lead with a customer first approach, focusing on the most valuable vision correct consumers in the category and leveraging proprietary technology to deliver a level of convenience, value and personalization that traditional eye care providers cannot match. Our foundation is built on acquiring and retaining a growing base of annuity like customers who return to kits for their evolving vision needs.

As we broaden our portfolio of eyewear and optical products, we aim to ensure that every customer visit is met with exceptional service, selection and value. During our last earnings call, we set out our Q2 revenue expectations at 48,000,000 to $50,000,000 with a targeted adjusted EBITDA margin of 3% to 5%. I’m proud to report we delivered record revenue of $49,600,000 up 31% year over year. This is our eleventh consecutive quarter of positive adjusted EBITDA, exceeding our guidance to reach $2,600,000 or 5.2% of revenue. We led the category in revenue growth with particularly strong performance in Canada, where revenue increased approximately 44% year over year, driven by both new and returning customers across glasses and contact lenses.

That growth was led by glasses, which grew 44% year over year and now represent a larger share of the business than ever before. Glasses have always been at the core of our long term strategy that would be the engine to drive our long term value creation. It’s a larger market, a more complex category and one where vertical integration especially matters. And Q2 showed the power of this business segment. We delivered over 112,000 pairs of glasses, up 53 year over year.

Header glasses revenues rose to $7,200,000 reaching another all time high. What’s especially exciting is the quality of these orders. Premium lens upgrades accounted for nearly 46% of glasses revenue and revenue from those upgrades grew 58% year over year. That’s a clear signal that our customers are increasingly choosing us for more personalized, higher value products. We continue to see repeat glasses orders grow each quarter with returning customers now making up over 52,000 glasses deliveries this quarter, an 18% increase over last year.

That kind of customer behavior through repeat purchases and premium upgrades is a powerful validation of the investments we have made in our optical lab, digital experience and branding of kits. During Q2, we saw continued improvement on margins. Gross profit grew 45% year over year, reaching $18,000,000 with gross margins expanding three fifty basis points year over year to 36.3%. We achieved this while absorbing record new customer growth, which typically carries lower AOV. We have now grown our two year active customer base to over 991,000 people, increasing 13% year over year.

That base is increasingly loyal with repeat customers representing over 60% of Q2 revenue. Performance was driven by balanced strength across both new and returning customers. We welcomed over 111,000 new customers, a record for kids and a 55% increase year over year. With this cohort, customers contributed to over 39% of revenue. We’ve also been thoughtful about how we invest to build this customer base.

Marketing spend increased to 15.2% of revenue in Q2, up from 13.4 last year. This new customer growth is not by chance, but by design. We’re not thinking short term. We are in the business of building lifetime customer relationships. In Q2, we strategically invested in acquiring high quality, high potential customers and guiding them into a long term relationship with kids.

That’s the essence of our model, delight customers with their first experience and build lifetime value through customer service and product quality. Looking ahead to Q3, we expect continued momentum, with revenue projections in the range of $52,000,000 to $54,000,000 and an adjusted EBITDA margin between 57%. Thank you again for your continued support. With that, I’d like

Joe Thompson, Chief Operating Officer, KITS Eye Care: to hand the call over to Joe, who will provide further details on our operational performance. Joe? Thanks, Roger. We are focused on delivering results today as well as launching the next wave of growth for kids. Fortunately, we have a number of initiatives that are helping us do both.

These franchises are now meaningful standalone growth businesses and each one plays a critical role in supporting both our top line trajectory and growing margin profile. We call these our fiftyfifty club, initiatives that are growing at about 50% year on year with approximately 50% gross margin. Leading the way in Q2 was our Digital Progressives business with growth well above 50% year over year and gross margin percentage also well above 50%. Our vertically integrated manufacturing is allowing us to maintain the highest level of quality while offering customers up to 90% of the cost of buying Digital Progressive in a brick and mortar store. Importantly, Digital Progressive customers are also demonstrating some of our highest Net Promoter Scores and some of the highest repeat rates, helping us achieve our goal of more lifetime relationships with more customers, as Roger mentioned.

We see no end in sight for our growth potential here. Additional high growth and high margin fifty-fifty club businesses that performed exceptionally well in Q2 include our premium lens portfolio, our insurance programs and our kits contact lens business. And the team has a collection of additional initiatives well on their way to fifty-fifty status. Our technology and digital led model is untethered to a legacy brick and mortar infrastructure. When connected with our onshore vertically integrated lab, it’s an enabler to move quickly.

We’re just starting to see how powerful this advantage can be for our customers and how much growth it could yield for our business. As an example, a digital led model allows us to innovate on important customer needs like glasses selection. In Q2, our glasses selection grew to over 10,000 styles, representing one

: of the most comprehensive eyewear catalogs in the industry. This expansion hasn’t come at the cost

Joe Thompson, Chief Operating Officer, KITS Eye Care: of efficiency as our technology driven approach has enabled us to achieve improved inventory turns while maintaining this fast selection. And starting in Q3, our digital led model is allowing us to go even further for customers. With innovations like OpticianAI, Kits is building a customized experience to allow customers to find the best frame, the best fit and the best lens based on their unique measurements, prescription and style. Early customers that have tried Optician AI have told us they now see the kids’ online experience as superior for them in selecting frames that fit in addition to offering them more convenience and more value for their dollar. Stay tuned for more innovation that will allow us to deliver results today while launching initiatives to power growth to Morim.

That’s a great segue to Zee, our CFO, to share details on our Q2 financial performance. Zee?

Zei Chew, Chief Financial Officer, KITS Eye Care: Thanks, Joe. After a strong Q1, we kept the momentum going in Q2, delivering another record setting quarter, fueled by strong execution, strategic growth in new customers and deeper engagement with our customer base. In Q2, we continue to scale efficiently while optimizing costs. Fulfillment expense as a percentage of revenue improved to 10.7%, down 50 basis points year over year. We processed over 269,000 orders this quarter, benefiting from ongoing efficiency in shipping and labor.

As we grow, we expect to see continued leverage in fulfillment, particularly through increased volume of glasses sales, which remains the key margin driver. As Roger mentioned, customer acquisition was a key focus in Q2, reporting a record of over 111,000 new customers who contributed over 39% of revenue in the quarter. To support this growth, marketing expense was 15.2% of revenue, up from 13.4% in Q2 last year. Despite the higher mix of first time customers, we saw a positive trend in total average order value, which increased to $184 up from $182 a year ago. We expect further AOV expansion as these new cohorts mature.

General and admin expense represented 7.3% of revenue, consistent with last year. We continue to manage overheads carefully, maintaining our focus on the scalable and efficient growth. We achieved a gross margin of 36.3%, a two fifty basis point improvement from 32.8% last year. This was driven by a higher mix shift towards higher margin glasses and lens upgrades, alongside with the tighter control over promotions. These gains reflect the strength of our vertically integrated model and our ability to optimize pricing and product strategy as we scale.

We did record a non operating foreign exchange loss this quarter due to the strengthening of the Canadian dollars. This impact was largely related to unrealized revaluation of intercompany balances and does not reflect underlying business performance. Excluding the exchange loss, net income was CAD1 million or CAD0.03 per share. Q2 twenty twenty five marked the eleventh consecutive quarter of positive adjusted EBITDA, which increased to CAD2.6 million, up from CAD1.3 million in the prior year at 5.2% of revenue as adjusted EBITDA margin exceeded our guidance and reflect 170 basis point year over year improvement, demonstrating our focus on driving margin expansion and operational efficiency across the business. This quarter, we paid $1,700,000 in principal, interest and a onetime cash sweep on our BDC facility.

We remain well capitalized with $18,100,000 in cash at the end of the quarter. With a strong balance sheet, scalable infrastructure and growing efficiency as we scale, we are well positioned to continue executing against our financial and strategic goals. As we expand our leadership in digital eye care to continue innovation, we remain confident in our ability to deliver profitable growth and create long term value for our shareholders. I’ll now turn the call over to questions.

Conference Operator: Thank you. Ladies and gentlemen, we will now begin the question and answer session.

: Session.

Conference Operator: Our first question is from Martin Landry from Stifel. Please go ahead.

Martin Landry, Analyst, Stifel: Hi, good morning guys and congrats on great results. Good morning, Martin. My first question, I’d like to dig on your revenues in Canada. Roger, you highlighted Canada as a had a pretty strong performance this quarter. I just want to understand a little bit, are your revenues in Canada concentrated in a few regions?

And if so, are there white spaces that you could expand to in Canada in the coming years?

Roger Hardy, Chief Executive Officer, KITS Eye Care: Yes. Thanks, Martijn. As you said and as we pointed out, we’ve had great success in Canada over the past couple of quarters, strong double digit growth across both parts of the platform and product categories, especially seeing double digit growth in frames and lens categories. So we’re excited about the way the value and what we’re doing is resonating in Canada. I’d say we’re seeing accelerating word-of-mouth in a few geographies.

So as you know, we’ve targeted a few more geographies a bit more specifically. The offer is resonating well there. We’re seeing increased order flow, increased returning customers. But it’s still very early days. I think we have a very small market presence and market share in Canada even with these growth numbers.

So there’s a long way to go from where we are today. I’d only identify a couple of geographies where people have even heard of kits, to be frank. So it’s very early days in a very large category and lots of opportunity ahead of us. We’re seeing our view is the future of eye care is going to be fast, it’s going to be personalized and it’s going to be digital first without sacrificing trust or quality. So we think KITS is building that first vertically integrated platform and it’s resonating with customers.

Anything I missed there, Joe? No, Joe’s okay with that. So thanks for the question, Martin.

Martin Landry, Analyst, Stifel: Okay. If I can just jump quickly into your glasses orders. You had a very strong quarter, 112,000 pairs were delivered. I think that includes 60,000 that were free. You know, if I do exclude that, it looks like your glasses delivered would be down year over year.

I assume you had free glasses last year as well that were provided. So if we exclude free glasses delivered in both this quarter and last year, how would your glass volumes would have evolved?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Hey, Martin. It’s Joe. Yes, we were thrilled with the glass’ performance in the quarter. The revenue up 44%, but really it was the unit and the new customers coming in through glasses that we were focused on in the quarter. The team was focused on in the quarter and we saw that increase up over 50%.

So to your question on the 60 approximately sixty thousand first pair free units, we did have first pair free in the market a year ago. So there is some in the base. Net of first pair free, our view is this was still an increase on new customers year on year. And maybe just to go a layer deeper on that, What we saw this year versus last year is maybe a few more tools in our arsenal within the glasses franchise. So Digital Progressive is playing an even bigger part of our business this year, up significantly, even higher than the overall growth of glasses and a few other parts of our glasses business.

Martin Landry, Analyst, Stifel: Okay. So just to be clear, if we exclude free pair of glasses, your glass volumes were up year over year?

Joe Thompson, Chief Operating Officer, KITS Eye Care: That’s right, Martijn.

Martin Landry, Analyst, Stifel: Okay, perfect. And then last question for me. Just looking at your average order value,

Roger Hardy, Chief Executive Officer, KITS Eye Care: was Martijn, it’s Roger. Just want to confirm on the 60,000 glasses, those are new customers, not necessarily just free customers, and so a slight difference there. Just want to make sure you got that. Happy to follow-up with you after the call just to make sure you’ve got it clearly. Thank you.

Martin Landry, Analyst, Stifel: Yes, super. Just lastly, on your average order value of $184 I assume that’s also impacted by your 60,000 pair of glasses free, right? So is it fair to say that, you know, if we adjust for that, your average order value would be closer to $237 Is that the right way to look at it?

Roger Hardy, Chief Executive Officer, KITS Eye Care: Yes, Martijn, again the 60,000 was new customers, a portion of those would be free, but we shouldn’t have them down at zero value per se. So no, that math would quite work. We can get back to you on what the average adjusted with those first pair freeze out would be. I would think about it more that the other the net new customers though were primarily would have had a lower average order size, but not freeze. Thank you.

Martin Landry, Analyst, Stifel: Okay. Yes. Sorry. Sorry, I see it now. Okay.

Got it. Thank you.

: Okay.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Anything else, Martin? Great. Operator, maybe we’ll move on to the next caller.

Conference Operator: No problem. The next question is from Gianluca Tucci from Haywood Securities. Please go ahead.

Gianluca Tucci, Analyst, Haywood Securities: Hi, morning guys. Congrats on a nice quarter.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Jean Lucis. Sorry. Good to see you.

Gianluca Tucci, Analyst, Haywood Securities: Joe, Roger, could you guys maybe update us on your own this town playbook? How far along are you guys? What still has to be done? And like just tying that into your elevated marketing spend right now, like do you foresee that 15 ish percent holding for the next couple of quarters? Or how should we think about that?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Hey, good morning, Gianluca. This is Joe. So yes, let’s talk on this town and then we’ll get into marketing spend second. So we do continue to make investments on this town, no change on our strategy there. And we were delighted to see the continued results in Q2.

So some of these seeds that were planted earlier just continuing to pay off with higher awareness in some key markets. Specifically, you’ll see it while we don’t break it out town by town, you see it really in the overall Canadian results which were up 44%. And this was our initial focus on On This Town. So where is the team focused now on On This Town? Well, the focus areas are one converting these initial customers and this initial awareness boost kits in the key markets that we have invested in.

And then two, planning for subsequent markets. So we won’t get into too much detail on where those markets are, but this continues to be an important tool in our arsenal. With regard to your question on marketing, as described, marketing was a little more elevated in Q2 up to around 15.2%. As we as you see in the Q3 guide of EBITDA in the range of 5% to 7%, we expect to see marketing as a percentage of revenue moderate a little bit, somewhere in the neighborhood of 50 to 100 basis points, I would imagine quarter on quarter. And we also expect to see a little bit of gross margin favorability quarter on quarter.

Gianluca Tucci, Analyst, Haywood Securities: All right. Perfect. Thank you, Joe. And actually that ties into my second question on your targets for the gross margin. As your glasses business continues to scale as it has very nicely and comprise a bigger piece of your revenue pie, what are the kind of short term and perhaps longer term targets on the gross margin side we should be thinking about?

Joe Thompson, Chief Operating Officer, KITS Eye Care: You bet, Gianluca. So no change again to our strategy on continuing to use our glasses business and the growth of our glasses business. In addition to continued leverage on size to take up gross margin percentage. So about a year and a bit ago it was low 30s. It’s now approaching higher 30% gross margin.

And our destination is 45% and above over the next three to five years. And so that will come as we see some of these franchises we talked about digital progressives, some of the other fifty-fifty club members, really helping to boost that. But yes, no change more of the same continued March up on gross margin. 45% is the next big milestone, over the next three to five years.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Perfect. Thank you guys. Thanks, Shantanu.

Conference Operator: Next question is from Lou Cannon from Canaccord Genuity. Please

: go ahead.

Lou Cannon, Analyst, Canaccord Genuity: Thanks. Good morning, everyone. I I wanted to follow-up on the the first carefree discussion. I know that this is a a tactic and a promotional tool that you’ve used in in the past, But what’s the ROI or I guess how do you measure the ROI on this? If you just want to look at it in terms of time of conversion from a new customer to a returning customer, the number of units that they maybe have in the basket, the upgrades to higher margin items like premium lenses for example.

If you look at the results from the most recent iteration of deploying your first pair free program and you measure that versus the first few instances where you would have used it, how does the ROI look now?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Hi, Luke. Good morning. So yes, on first pair free again and maybe we’ll frame this, we’ll get into the details on first pair free, but it is one tool in our arsenal and it’s one that customers love. And so the way we think about the economics of First Pair Free is, it’s an investment in product to be sure where it’s an invitation for customers to try us out. Typically customers will make some type of purchase alongside the first pair free.

So it’s typically not a $0 average order value. But where we look to the economics is a mix of lower cost of acquisition. So instead of spending in the category $100 to $200 is the average cost of acquisition for prescription glasses. And our cost of acquisition is far, far lower. Thanks to promotions like First Pair Free.

So blending down cost of acquisition and taking making an investment in the customer in that first purchase with the view that they’ll be so blown away by their experience, by the quality of the glasses that they’ll come back and become lifetime customers. And so to your question on return on investment, we typically look at first customers that while the market looks at repeat in the eighteen to twenty four month range, we tend to cut that in half and set the target at can we do it in six to twelve months or sub twelve months to get that repeat customer coming back. And that’s the target team works against, and we’ve been very happy with the results. And that’s why we keep investing in it.

Lou Cannon, Analyst, Canaccord Genuity: That’s great. Thanks so much for that color. I also wanted to follow-up. Joe, you touched on the learnings thus far from the Own This Town initiative and I think I imagine in subsequent rollouts across various geographies both in Canada and then south of the border, you’re only going to fine tune that even more. Has there anything has there been anything that’s come out of the initiatives to date that you believe has helped inform or maybe fine tune your approach for when you eventually deploy this a little bit more meaningfully in size south of the border?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Yes, Luke, still very much in our plan. As you know us by now, we are we test, we iterate and then we roll out. And that’s exactly what we’re doing with Own This Town, alongside a number of other initiatives. Every time we execute First Pair Free each quarter, we think the experience gets a little bit better. We think the economics get a little bit better.

And we think the value for customers gets a little bit better. Same with Own This Town. So I think we’ll probably have more to share in quarters to come on it. I think what I would say is the tailwind that promotions like Own This Town and First Pair Free deliver are in the overall economics. So if you look at traffic, which is a good read for word-of-mouth and cost of acquisition, we saw traffic up again ahead of our growth rate over 100 in the quarter.

Lots of exploration on the site, leading indicator for us of interest in demand. And a big part of that is driven by some of this awareness and curiosity around tactics like First Pair Free and on this town. Another driver that we see, especially when you see other consumer companies, see marketing really being a cost item that goes up and up. Well, if you look at our performance in Q2, we saw average order value increase year on year, up about 1% and cost of acquisition was down in the neighborhood of around 9% to 10%. And on glass is even more significant than this.

So for us, we look at the whole picture. It’s not just one gross margin line. It’s not just one AOV line. It’s the whole thing, including cost of acquisition. And then I think as Roger referred to in the prepared remarks, the mission is building the lifetime relationship with that customer.

And we’re happy with the short term economics for sure and you see it in our results in Q2. But what we’re really focused on is that lifetime relationship with the customer.

Lou Cannon, Analyst, Canaccord Genuity: That’s great. Last question for me and then I’ll pass the line. Had mentioned the inventory, the number of styles that you have now, I believe it’s over 12,000 and if we were to go back a quarter ago, it’s just under 7,000. So that is a big step up but no real meaningful meaningful change appears in

Roger Hardy, Chief Executive Officer, KITS Eye Care: as far

Lou Cannon, Analyst, Canaccord Genuity: as investment and working capital. So I guess it’s probably a tough question to answer, but how is it exactly that you’re now able to offer so many styles without it necessarily becoming a burden on your cash flow from operations going forward?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Sure. Yes. No, we’re delighted to talk about things like inventory and increasing selection for customers. This is really where we’re untethered to a legacy brick and mortar network of hundreds or even thousands of stores. And having a digital led model allows us to plug in more selection and have it be demand driven really led by the customer, how they’re browsing, what they’re looking for and to go wide with our selection, but shallow with our inventory levels.

And what you should expect from us is that we get better and more efficient every quarter, every year on that. So that we’re not burdening cash flow and we’re not burdening cash flow from operations from inventory. And so we were and I think you called this out last quarter, we were a little bit higher in Q1 and our commitment was to come down in Q2 and the team delivered on that down about CAD 4,000,000 quarter on quarter.

Lou Cannon, Analyst, Canaccord Genuity: That’s great. Thank you very much.

Conference Operator: Your next question is from Kyle McPhee from Cormark Securities. Please go ahead.

Kyle McPhee, Analyst, Cormark Securities: Hi, everyone. I just want to quickly chat on the balance between the level of margins and the level of growth beyond just the Q3 color we already talked about. Now you’ve been leaning more aggressively into growth lately. It’s working. The new customers are arriving.

All the evidence suggests you’re keeping them for the repeat purchase cycles. How should we expect this balance of growth risk margins to evolve through the rest of 2025 and into 2026? Do you plan to keep the pedal down on growth given it’s working so well? Or do you think you’ll opt to unleash larger margin expansion sooner rather than later? You seem to have total control over this decision, so just please give us a preview of what you’re thinking kind of midterm.

Joe Thompson, Chief Operating Officer, KITS Eye Care: Good morning, Kyle. Yes, thanks for the question. So what we saw in Q2 and we wanted to demonstrate is that we share your point of view that we really do feel like we have control of the dials. In some quarters, we’ll dial up the EBITDA levels and some will invest a little bit more into future growth. So as we look, maybe we can talk specifically to Q3.

I think we’ve said this will be our third quarter or our fourth quarter of that we’re guiding to plus 5% adjusted EBITDA margin in the 5% to 7% range. So specifically in Q4, seeing some we expect to see some favorability on marketing and some gross margin favorability. And then we’ll see how we’ll have more to share on how far these numbers could reach into Q4. But really no change more of the same story from us. Our next milestone on EBITDA over the next few years is to cross 10% on adjusted EBITDA and then within five years to be in the 15 to 20% range.

All indications we’re seeing on the business are that we’re right in line with that plan. So no change. It will be the drivers continue to be the same drivers, glasses and more expansion with more parts of our fifty-fifty club including premium lenses, Sun Rx, kids brand contact lenses, kids colors and of course digital progressives.

Kyle McPhee, Analyst, Cormark Securities: Okay. Thank you for that color. Next question. A lot of the evidence in your results is suggesting that while you’ve been thinking more aggressive marketing and growth spend that you’re skewing more of these kind of growth dollars into onboarding customers in the eyeglasses platform versus contact lens. Am I reading too much into the details to make this conclusion or is it true you’re in fact making a relatively more aggressive push with growth spend in the eyeglasses category?

Joe Thompson, Chief Operating Officer, KITS Eye Care: What I would say, Kyle, is we do talk a lot about our growth in glasses, and we were delighted with the performance. But you’ll see, as you break it down, we onboarded a number of new customers in contact lenses and that continues to be just a terrific workforce workhorse for us. Customers in contact lenses are looking for more value and they’re looking to the online channel to deliver it. So we continue to invest, contact lenses continues to grow. But I think you’re right to call out that we could talk a little bit more about that in both prepared remarks and in some questions.

So thanks highlighting it.

Kyle McPhee, Analyst, Cormark Securities: Okay. And then I’m curious on one specific dynamic within the base of eyeglasses revenue you have. You seem to be adding more and more third party branded options to the platform. Is there a noticeable revenue mix shift starting to occur in your eyeglasses revenue mix away from kits branded? Can you talk through the impact on your margins when a customer does opt for third party branded frames?

So, example, for a given lens type, is there a noticeable difference for gross margin percentage on that sale or more importantly, gross margin dollars on that sale when they opt for third party branded?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Sure, Kyle. So I’d say on the mix, the mix has maybe been marginally increasing to branded, but it was coming from a lower base. I think we were for the first few years of our building our glasses franchise, we were really solely focused on the kids brand. And so we’ve been expanding that selection. And but still the frames frame levels as a percentage of total frames is still north of 80% our kits.

We don’t expect that to shift too dramatically. Each designer frame still comes with a kits prescription lens and still comes delivered in a kids box. Regarding gross margin levels, on percentage, the levels are comparable. So no real change, But with a higher average order value on some branded frames, gross margin dollars would be higher. You’re right to call that out.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Great. Okay.

Kyle McPhee, Analyst, Cormark Securities: Thanks for all the answers. I’ll pass it on.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Thanks, Kyle.

Conference Operator: Your next question is from Doug Cooper from Beacon Securities. Please go ahead.

: Hey. Good morning, and terrific work. Just a couple just to start with, I just want to confirm, I think something you said, Roger, in the opening. Can you tell me progressives as a percentage of glasses sales? Like what percentage of glasses sales include progressive lenses?

What was that number?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Doug, it’s just I would say north of 10% of the orders on the glasses side. Don’t break out the exact number, but it’s north 10 and growing very rapidly.

: Okay. And what do you think the general market of people who wear glasses use progressives? I guess I’m just trying to get to what do you think it can ultimately be of your glasses portfolio?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Maybe I’ll start, Doug, and then pass it on from here. But we think the next milestone is 20%. I think if you look at the dollars in the category, the dollars in the category broadly and this is U. S. Data is north of 40% of the dollars in the category are driven by progressive.

And part of that is just the price point is so high in the market for Digital Progressives $800 to $1,000 And on kids.com or kids.ca, you can get Digital Progressives for under $200 And that’s part of the reason why delivered in a day or two. And that’s part of the reason why the repeat net promoter score is so high. And that business just continues to grow. But I think so I think 40% would probably be high in the short term. But certainly 20% and north of 20% is would be the next milestone we’ll be looking at.

But let me just stop there.

: Okay. And just to be clear, the 10% number you gave me is dollars or units? I think it’s units, right?

Joe Thompson, Chief Operating Officer, KITS Eye Care: That’s units, correct.

: Okay. You mentioned earlier, you know, targeting gross margin ultimately 45% plus. And maybe just in terms of the the next milestone of 40%, which you’ve mentioned in the past, what percent of total revenue needs to be glasses to get to that level, in your opinion? Right now, are sitting at 14.5% of total revenue.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Think the way we’ve been thinking about it, Doug, is to continue to grow in a balanced way. So we’ve been balancing growth and earnings across both contact lenses and eyeglasses. And that’s kind of the way we’re thinking about how to continue the growth. So as Joe talked about a steady progression up north of 40 over time with glasses starting to drive a more meaningful percent of gross margin dollars. Having said that, we still believe the most valuable customer in the category is the one we acquire first, that twenty to thirty something year old fashion conscious person that needs vision correction.

We believe when we acquire them and really wow them that they become a customer for life. And that’s been our goal since we started to really serve that customer in a way that makes eye care easy for the next generation. And so to the extent we’re able to do that, acquire them as a contact lens customer in their 20s, keep them in their 30s as they age into glasses. And then as they come into the 40s and the progressives become a part of their life, we’re able to retain them as a customer. So that’s kind of the life cycle that we’re seeing.

It’s still very early days. So as you’ve heard us say before, the eyeglasses category is much bigger than the contact lens category. So we still have a cohort of young customers that over time are going to move into glasses. And then over time will be in Progressive. So it’s an exciting time, but it’s early days.

So as we progress through that life cycle, we’ll continue to stay balanced in our approach, growth and earnings, like we’ve talked about in the past, and balance the portfolio between acquisition and then migration into the next parts of the value chain.

: Okay. Just getting back to this sort of, you know, what the profile of this company can look like in the next three to five years, Joe, if you’ve mentioned the goal is 45% plus gross margin. Did I hear you correctly in the same, ultimately, at 45% plus gross margin that would translate to EBITDA margin in your opinion of 15% to 20%?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Hi, Doug. Yes, no, haven’t put a specific year on that, but those numbers are that’s where we’re progressing towards about a 45% gross margin and then north of that yielding a 15% to 20% adjusted EBITDA number. Steady progress every year, every quarter.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Okay. Think obviously, Doug, leverage in that is accelerating word-of-mouth. To the extent marketing stays consistent, have and to the extent you have increased trust with customers and positive experiences, gross margin goes up and the rest flows through. We’ve got a lot of capacity in our facility today. And so we don’t see a ton of expense as that growth occurs.

: All right. And just to be clear, guess, the end of the day, you’re it looks like you’re about to pay off the rest of your debt in the next quarter or two. So you’ll be debt free. So there’s no really I and then there’s not much D in the business. So that’s almost pretax earnings levels.

Just moving on on the technology side, I just wanna focus the Optician AI. Early days, but you’ve gotten some positive feedback on frame selection and so forth. You know, I I think there’s some technology out there that gives prescriptions in, I think, it’s as quickly as ninety seconds through an ATM like machine out there. Is that something you can migrate to online? Or maybe just talk about the next level of technology to actually get prescriptions online and just do that, the total one stop shop?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Yes, you bet, Doug. Maybe I’ll start and then I’ll pass the mic on because this is an important topic for us. So I think yes is the short answer to your question. I think it all will migrate online. That’s our view and that’s what we’re seeing with the technology.

And so early days in OpticianAI, we’re delighted to get this technology out there. And the more customers come through, the more data we have, the faster it iterates and improves each week, each month, each quarter. And as we look to this technology, we expect it to be a game changer on customer engagement over time and lifetime value. As the customer comes in and they can customize the right frame based on their face shape, their unique measurements, their style, their prescription and that’s recorded in their customer file. It’s an easy return for that customer to come back and say, this is almost a custom fit for me on frame, on lens, on experience, on style.

And it has to selection has to continue to grow alongside. We need to have the right lenses available all those things. But overall this is we see a big LTV boost. And short term, I think there’s some other favorabilities on conversion, on a net promoter score and on word-of-mouth that we’re looking forward to as well. But maybe I’ll pass the mic and just see what I missed there from Zee and Roger.

Roger Hardy, Chief Executive Officer, KITS Eye Care: I think you covered it, Joe. I mean, I think it’s exciting for KITS and for the people at KITS to be leading the category in terms of innovation, in terms of pushing the category to new highs. I can say I’ve frankly never heard from so many of our quote unquote competitors or others in the category sending us questions and emails, congratulating us on Optician AI, and starting to see really where category can go with the help of technology. So it’s an exciting time. It’s an exciting time to be at kits when we’re leading this transition and integrating technology in a way that makes things easier for customers.

And I guess that’s kind of the excitement of it. It is still early, as Joe said, but customers are telling us they like the experience already and it can only get better. And it’s helping them have confidence in buying online, it’s improving the order flow. And over time, I think we see it becoming a cornerstone of how customers experience Vision Care. It will become even more personalized, it will become more intelligent, and provide accessibility to customers.

So it’s just an exciting time and place for us, Doug. Thank you. Okay.

: Just the last one for me. Just getting back to the earlier question on on this town. When and maybe you don’t wanna put a specific date on it, but when do you think or, you know, myself in Toronto or other clients in Montreal will will will be able to see with our own eyes the owners’ town in our specific cities?

Roger Hardy, Chief Executive Officer, KITS Eye Care: I mean, probably the best news, Doug, is when you’re saying you don’t see it yet, because it tells us how much opportunity there really is there and how early the days really are. You’ve seen the progress we’ve made in markets where we have launched. So we don’t need to telegraph everything, but I think you’re going to you’ll start to see us in more obvious ways over the coming months and days. Anything you want to add there, John?

Joe Thompson, Chief Operating Officer, KITS Eye Care: No, it’s perfect.

: Okay, perfect. Yes, we’ll continue

Roger Hardy, Chief Executive Officer, KITS Eye Care: to keep it balanced, Doug. Thank you.

: Okay. Thanks, Roger.

Conference Operator: Your next question is from Frederic Tremblay from Desjardins Capital Markets. Please go ahead.

Frederic Tremblay, Analyst, Desjardins Capital Markets: Thank you. Good morning. Just wanted to follow-up on the the Optician AI. I know it’s early days, but wondering if you’re seeing any benefits from that in terms of adoption of premium products from from customers that have used Optician AI so far.

Joe Thompson, Chief Operating Officer, KITS Eye Care: Good morning, Farik, and welcome to the call. So, yes, I will caveat this by saying it is early days, but really the intent is to help customers find the perfect frame and the perfect lens for them. I think you’re right to think that for a number of customers this will allow them to be introduced to our broad lens portfolio in a new way. And so some examples of that are some of the technology that we have on thinner frames and some of our unique coatings in addition to a number of other in mass blue blocker or blue light glasses. And so that is our expectation that we will see more lens upgrades that business will continue to perform helped by OpticianAI.

But I would say that’s not the design is really around building a lifetime relationship with that customer and building trust. I think as Roger put it really well earlier with that customer that the online experience if you think if you were to plot on a grid five, ten, fifteen years ago, the in store experience versus the online experience for the general population, that experience is getting closer and closer together to the point where our view is technologies like optician AI, the intercept point will happen where the population says, wait a minute, this is actually it’s actually better to go online to get great fitting, perfect fitting frames with a guarantee and the right lenses that come with them based on my unique measurements and in addition to offering great value and great selection. So that’s mostly what we’re excited about. But yes, we do expect it to yield some greater upgrades on the lens side.

Frederic Tremblay, Analyst, Desjardins Capital Markets: Understood. That’s really helpful. Maybe just a segue into into competition, you know, excluding Optician AI and and other technology tools. Are you seeing any changes lately in the competitive landscape, you know, whether it’s, you know, new entrants or changes in the promotional activity, anything to highlight there?

Roger Hardy, Chief Executive Officer, KITS Eye Care: No. I mean I think as usual, we tend to stay focused on our business and thinking about how we can do a better job for customers and how we can improve service times and improve quality. So we don’t spend a lot of time looking outside at like I said, one of the rare times we’ve heard from so many of the others in the category was with the launch of Optician AI. But otherwise, we’re heads down focused on how to wow customers and how to keep our keep growing and keep leveraging efficient model to the extent we can to help customers. So nothing to report.

Frederic Tremblay, Analyst, Desjardins Capital Markets: Okay. And then maybe last question for me. Given the significant success in attracting new customers and, you know, historical retention as well, which is quite strong. I wanted to understand a bit better the path for AOV. You know, I understood that the second order is typically higher than the first order, but what about, you know, third and fourth orders?

Are you still seeing AOV growth for those those cohorts of customers that have been around for for more than two orders? Just wanting to see if there’s a continued rise in AOV for those customers or if we plateau at some point?

Roger Hardy, Chief Executive Officer, KITS Eye Care: Yes. And we do watch those and monitor them. We don’t break it out at this point, but we do see as we move into years three and beyond an increase in the LTVs of customers. At this point, still driven primarily by the contact lens customer, obviously the glasses AOVs have been going up over time. So that cohorts improving.

And then we do see a we’ve talked about it before, a small percent of customers that really give us their entire basket of optical, and it tends to be quite a while, the extent that people can invest in the optical category. But yes, we’re continuing to see those cohorts get stronger over time and look to continue that. As I think to tying it into your question about Optician it’s interesting the number of prompts and so on that we can work with Optician AI, really AOV and those types of things will be driven by understanding customer needs. So figuring out if somebody needs a prescription sun or if they need a photo chromatic lens that can change from light to dark depending on sun and so on. So there are lots of and then someone moves into progressives understanding those needs.

So over time, like we talked about earlier, we see the progression, a natural progression as customers age, that their vision care needs increase, the spend increases, the AOV goes up over time. And then we our goal is to make sure we’re standing at the ready to wow them with even better and better products over time that fulfill those needs.

Frederic Tremblay, Analyst, Desjardins Capital Markets: Okay, that’s great. Thank you.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Thanks.

Conference Operator: Your next question is from Matt Koranda from ROTH Capital. Please go ahead.

Lou Cannon, Analyst, Canaccord Genuity: Hey, guys. Good morning. Just wanted to get your thoughts on the pricing environment in Optical in general. I guess a lot of your larger, more traditional peers have been taking price in various ways over the last six months or so. Does that give you guys room to do the same?

Or do we sort of just let the price gaps grow and trying to generate market share gains? Is that sort of the strategy here?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Hey, good morning, Matt. So we see some data on pricing. It’s mostly U. S. Based and the data that we’ve seen is consistent with yours where the market is really seen in some cases north of 10% price increases, is that’s pretty significant on the average pair of prescription glasses in The U.

S. Last year cost north of $300 around $350 10% is that’s a big increase. And so if that continues, it gives us comfort that the consumer is going to be looking for fair value more than ever. And we think about pricing, we think about our pricing is really in the $38 to $58 range about 80% of our selection is priced in on the kits line up in that range of $38 to $58 And that includes a prescription lens. So that’s the frame, the lens made the same day it’s ordered and shipped to you in a day or two.

So for us that really feels like we’re yielding great gross margin on that. We’re getting more efficient every quarter and we’re delivering a great experience for customers. And if we can continue to do that, our one option is to take up pricing considerably as we see in the market. But where that comes at a cost is on cost of acquisition and on retention. And so we’re comfortable where we are right now in the $38 to $58 range for the majority of our kits line up.

We think the feedback we’re hearing from customers and the word-of-mouth and retention data suggests that we’re offering something that’s very unique and very valued. And so we’re going to stay focused on that and we’ll kind of update you in the market quarter on quarter.

Lou Cannon, Analyst, Canaccord Genuity: Okay. That makes sense. Thanks, Joe. And then for the third quarter EBITDA guidance range, I may have missed this earlier as I rolled on a little late. But I guess, does that margin dynamic look similar to what we saw in the second quarter where most of the improvement came from gross margins and then reinvested in OpEx line items like marketing?

Maybe just a little bit more color on sort of how we get to the 5% to 7% range.

Joe Thompson, Chief Operating Officer, KITS Eye Care: Sure. Yes. Maybe some just some broad thinking from our side, still early days in the quarter. But what we expect this is our we’re guiding to our fourth quarter of over 5% adjusted EBITDA margin with a 5% to 7% range. As we think quarter on quarter, so at the midpoint that’s about two twenty basis points improvement year on year.

But to your question on quarter on quarter, we expect favorability on the marketing line in the neighborhood of 50 to 100 basis points plus or minus a little bit quarter on quarter and some gross margin favorability. And then just to be conservative, we’ll assume the other line items are flat quarter on quarter. So that’s where we see the growth. And we’ll look forward to updating you and the market as the quarter progresses and as we wrap and go into Q4.

Lou Cannon, Analyst, Canaccord Genuity: Okay. Makes sense. Maybe just one more from me. Just with the glasses unit growth accelerating this last quarter, where do we stand on capacity utilization currently? And sort of maybe how do you think about the gross margin lift that you may get as utilization further improves?

Joe Thompson, Chief Operating Officer, KITS Eye Care: Yes. Thanks, Matt, for bringing that up. Lots of we have built a significant amount of capacity we think at least that will support us at least to $500,000,000 in revenue and beyond. And I think the mix on gross margin appreciation, there will be some efficiency gains, which will hit the gross margin line, maybe kind of a third of the gross margin improvement, maybe slightly above that. And the balance will just be mix as we sell more glasses and more premium parts of the glasses business as well.

Lou Cannon, Analyst, Canaccord Genuity: I appreciate that. I’ll jump back in queue guys. Thanks.

Kyle McPhee, Analyst, Cormark Securities: Thanks, Matt. Thanks, Matt.

Conference Operator: There are no further questions at this time. Please proceed with closing remarks.

Roger Hardy, Chief Executive Officer, KITS Eye Care: Thank you, operator, and thanks to everyone for joining us today. Q2 was another quarter where we focused on the fundamentals, showing strong growth through our disciplined execution, ultimately making steady progress towards our long term goals. We saw record customer growth and strong momentum in glasses and did it all with a clear focus on margin and capital efficiency. We’re still early in the kit story. Each quarter, we see more evidence that the model is working.

Our glasses business continues to scale and our ability to compound value is becoming clearer. That’s what excites our team, not just the growth today, but what that growth will mean years from now. KITS will continue to play the long game and remain focused on building a company that lasts, driven by customers who come back to a company that has proven to deliver. Thanks to our team, our customers and our shareholders for the continued belief in the mission we are building.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.